Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Share-based Compensation (2016 - 2025)

Firefly Neuroscience has reported Share-based Compensation over the past 15 years, most recently at $12000.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $12000.0 for Q4 2025, down 99.53% from a year ago — trailing twelve months through Dec 2025 was $321000.0 (down 87.78% YoY), and the annual figure for FY2025 was $45000.0, down 98.27%.
  • Share-based Compensation for Q4 2025 was $12000.0 at Firefly Neuroscience, roughly flat from $12000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for AIFF hit a ceiling of $2.6 million in Q4 2024 and a floor of -$227000.0 in Q4 2023.
  • Median Share-based Compensation over the past 5 years was $88159.0 (2023), compared with a mean of $322123.8.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 31321.91% in 2021 and later crashed 355.33% in 2023.
  • Firefly Neuroscience's Share-based Compensation stood at $1.6 million in 2021, then crashed by 94.61% to $88903.0 in 2022, then crashed by 355.33% to -$227000.0 in 2023, then skyrocketed by 1227.31% to $2.6 million in 2024, then plummeted by 99.53% to $12000.0 in 2025.
  • The last three reported values for Share-based Compensation were $12000.0 (Q4 2025), $12000.0 (Q3 2025), and $50000.0 (Q2 2025) per Business Quant data.